GlassScriptPhysician profile
Joey R Levin
NPI 1245679810
$580.77
in general payments reported to CMS, 2019-2025
10 companies · $425 in 2025
The $425 reported for 2025 was more than what a typical Physician Assistant provider received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2023: $141 · 2024: $14.81 · 2025: $425.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $581.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $580.77 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Bioprotect Medical, INC. | $165.12 | 2025 | Bioprotect Balloon Implant System |
| Merck Sharp & Dohme LLC | $109.81 | 2025 | Keytruda, Lynparza |
| Intuitive Surgical, INC. | $93.49 | 2023 | Da Vinci Surgical System |
| Dendreon Pharmaceuticals LLC | $64.86 | 2025 | Provenge |
| Janssen Biotech, INC. | $44.28 | 2023-2025 | Erleada |
| Bayer Healthcare Pharmaceuticals INC. | $28.79 | 2025 | |
| Astellas Pharma US INC | $24.13 | 2025 | Xtandi |
| 180 Medical, INC. | $18.02 | 2023 | |
| Sumitomo Pharma America, INC. | $17.36 | 2025 | Gemtesa |
| Urogen Pharma, INC. | $14.91 | 2023 | Jelmyto |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Joey Levin listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.